• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Overview of the impact of conventional systemic therapies on breast cancer.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Howell, Anthony
    Wardley, Andrew M
    Affiliation
    CRUK Department of Medical Oncology, University of Manchester, Christie Hospital, 550 Wilmslow Road, Manchester M20 4BX, UK. Anthony.Howell@christie-tr.nwest.nhs.uk
    Issue Date
    2005-07
    
    Metadata
    Show full item record
    Abstract
    Survival in women with breast cancer is improving in the western world, in part related to improved surgery, radiotherapy and adjuvant systemic therapy. Aromatase inhibitors are superior to tamoxifen in this clinical situation and several studies indicate that taxane-based chemotherapy is superior to non-taxane-based regimens. Herceptin is active alone in HER-2/neu +ve advanced breast cancer and four clinical trials are testing this agent in the adjuvant situation. It seems likely that herceptin will add to conventional therapies and thus will be the paradigm for the introduction of other biological therapies to improve cure rates.
    Citation
    Overview of the impact of conventional systemic therapies on breast cancer. 2005, 12 Suppl 1:S9-S16 Endocr. Relat. Cancer
    Journal
    Endocrine-Related Cancer
    URI
    http://hdl.handle.net/10541/84452
    DOI
    10.1677/erc.1.01003
    PubMed ID
    16113103
    Type
    Article
    Language
    en
    ISSN
    1351-0088
    ae974a485f413a2113503eed53cd6c53
    10.1677/erc.1.01003
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Trastuzumab: targeted therapy for the management of HER-2/neu-overexpressing metastatic breast cancer.
    • Authors: Emens LA
    • Issue date: 2005 May-Jun
    • Achievements in systemic therapies in the pregenomic era in metastatic breast cancer.
    • Authors: Colozza M, de Azambuja E, Personeni N, Lebrun F, Piccart MJ, Cardoso F
    • Issue date: 2007 Mar
    • Systemic adjuvant therapies and radiotherapy to the conserved breast: strategies revisited.
    • Authors: Bartelink H
    • Issue date: 2007 Dec
    • [Herceptin therapy in breast cancer: new indication?].
    • Authors: Lebeau A
    • Issue date: 2006
    • [Trastuzumab (Herceptin) in the adjuvant treatment of HER-2-positive early breast cancer].
    • Authors: Láng I, Hitre E
    • Issue date: 2006
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.